REQUEST A DEMO
Total
USD $0.00
Search more companies

Sandoz D.d. (Slovenia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Sandoz D.d. Profile Updated: November 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sandoz d.d. is a Slovenian company active in the pharmaceuticals sector. It is a wholly-owned subsidiary of local Lek d.d., which is part of Germany-based pharmaceuticals producer Sandoz. The German company is the generic pharmaceuticals division of Swiss group Novartis.Sandoz d.d. is mainly engaged in the wholesale and retail trade of generic medicines, dietetics, cosmetics and personal hygiene products, as well as other medical supplies. The customer base Sandoz d.d. comprises drugstores, hospitals and individual clients across Slovenia.

Headquarters
57 Verovshkova Street
Ljubljana; Osrednjeslovenska; Postal Code: 1000

Contact Details: Purchase the Sandoz D.d. report to view the information.

Website: http://www.lek.si

Basic Information
Total Employees:
Purchase the Sandoz D.d. report to view the information.
Registered Capital:
Purchase the Sandoz D.d. report to view the information.
Financial Auditors:
Purchase the Sandoz D.d. report to view the information.
Incorporation Date:
January 13, 2026
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Internal Member of Board of Directors
Purchase this report to view the information.
Internal Member of Board of Directors
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Predstavnishtvo Sandoz Pharmaceuticals D.d. (Serbia)
100%
Company Performance
Financial values in the chart are available after Sandoz D.d. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.45%
Total operating revenue
11.8%
Operating profit (EBIT)
-53.18%
EBITDA
-49.13%
Net Profit (Loss) for the Period
11.61%
Total Assets
5.05%
Total Equity
83.59%
Operating Profit Margin (ROS)
-2.61%
Net Profit Margin
0.01%
Return on Equity (ROE)
-29.36%
Debt/Equity
-482.1%
Quick Ratio
-0.3%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?